Talk:NNC 63-0532

This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles ??? This article has not yet received a rating on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about NNC 63-0532. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

US7081463B2 Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders

Above I provide the original patent. I did not add it to the page as I added 857 CORRECT patents to medicines ovcer 3 years and over 500 of them were removed. I used Reaxys & Drugfuture to confirm that the patents were cvorrecvt and yet they were removed. The best example is that I added patents to every sing barbiturate and they have ALL gone. I would like to know why as patents are of great utility to those in postgraduate studies in medicinal chemistry. I was reduced to releasing the Eunoia disc with EVERY patent on it and I know 1000s of copies are in circulation.